fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » UTI Healthcare Fund

UTI Healthcare Fund - G

NAV  ₹284.107 ↓ -1.03  (-0.36 %) as on 4 Nov 24

(Erstwhile UTI Pharma & Healthcare Fund)

Scheme Objective

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a CAGR return of 15.4% since its launch.  Ranked 40 in Sectoral category.  Return for 2023 was 38.2% , 2022 was -12.3% and 2021 was 19.1% .

Below is the key information for UTI Healthcare Fund

NAV as on 4 Nov 24₹284.107 ↓ -1.03  (-0.36 %)
Net Assets (AUM) as on 30 Sep 2024 ₹1,201 Cr.
Launch Date28 Jun 1999
CategoryEquity - Sectoral
Rating
TypeOpen Ended Fund
RiskHigh
AMCUTI Asset Management Company Ltd
Alpha Ratio1.27
Expense Ratio2.38 %
Sharpe Ratio2.507
Information Ratio-0.21
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Nov 24

DurationReturns
1 Month -1%
3 Month 7.8%
6 Month 26%
1 Year 56.4%
3 Year 20.1%
5 Year 28.1%
10 Year
15 Year
Since launch 15.4%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2023 38.2%
2022 -12.3%
2021 19.1%
2020 67.4%
2019 1.2%
2018 -7.5%
2017 6.2%
2016 -9.7%
2015 12.4%

Growth of 10k Over Years

DateValue
31 Oct 19₹10,000
31 Oct 20₹15,449
31 Oct 21₹19,772
31 Oct 22₹18,618
31 Oct 23₹21,719
31 Oct 24₹34,592

Asset Allocation

Asset ClassValue
Cash3.26%
Equity96.63%
Debt0.11%

Sector Allocation

SectorValue
Health Care94.08%
Basic Materials1.3%
Financial Services1.24%

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
Drug Manufacturers - Specialty & Generic12%₹142 Cr735,274
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
Drug Manufacturers - General6%₹74 Cr450,000
↓ -19,180
Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331
Drug Manufacturers - Specialty & Generic5%₹64 Cr200,000
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY
Drug Manufacturers - Specialty & Generic5%₹59 Cr87,100
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP
Medical Care Facilities4%₹47 Cr64,796
Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 532296
Drug Manufacturers - Specialty & Generic3%₹42 Cr250,331
Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL
Drug Manufacturers - Specialty & Generic3%₹40 Cr74,000
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 532843
Medical Care Facilities3%₹39 Cr634,445
Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERIS
Drug Manufacturers - Specialty & Generic3%₹37 Cr275,361
↓ -22,385
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA
Drug Manufacturers - Specialty & Generic3%₹37 Cr250,000
1 - 10 of 42
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
Kamal Gada2 May 222.42 Yr.

Custodians

CompanyAddress
Bank of Nova Scotia12/13, Maker Chamber VI,220, Nariman Point
Citibank N.A. IndiaTrent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East),
Stock Holding Corporation of IndiaMittal Court, ‘B’ Wing,,Nariman Point

Registrar & Transfer Agent

KFin Technologies Ltd
Address138 -Suyesh Solitaire, Nr. Podar International School,Kudasan, Gandhinagar, Gujarat
FAXN.A
EmailN.A

Administrator Companies

CompanyAddress
UTI Mutual FundUTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E)

Auditors

CompanyAddress
Haribhakti & Co. Chartered Accountants42, Free Press House,4th Floor,,215, Nariman Point,

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
UTI Healthcare Fund
Growth
₹284.107
↓ -1.03
26.05 %56.39 %20.12 %28.08 %
UTI Healthcare Fund
Normal Dividend, Payout
₹219.575
↓ -0.80
26.05 %56.39 %20.12 %28.08 %
UTI Healthcare Fund
Normal Dividend, Reinvestment
₹219.575
↓ -0.80
26.05 %56.39 %20.12 %28.08 %
Data as on 4 Nov 24

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.